Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Rapala H1'25: Toward a Turning Point

By Thomas WesterholmAnalyst
Rapala VMC

After several challenging years, Rapala's early 2025 figures suggest a shift toward better performance. Sales in the United States have been particularly strong. CEO Cyrille Viellard comments on the developments in the video.

 

  • 00:00 Introduction

  • 00:28 H1'25 overview

  • 01:07 Strong growth in the U.S.

  • 03:00 Tariffs

  • 03:56 Potential production relocation to the U.S.

  • 06:22 Sales outside the U.S.

  • 07:34 Cost structure

  • 09:30 Guidance remains unchanged

  • 11:40 Financing structure

  • 14:40 New strategy expected by end of year

  • 16:08 Rapala’s future and ownership structure

Stay up to date
Company management interviews

Recent videos

Herantis Pharma Plc, Phase 1b biomarker data webcast
08.01.2026 klo 12.00 Herantis Pharma
Investor Day | Nov. 24, 2025
23.12.2025 klo 12.00 United Bankers
Talenom - Planned demerger and strategies of Talenom and Easor
18.12.2025 klo 12.00 Talenom
Investing in the life science sector
18.12.2025 klo 08.47
Life Science Companies as Investments | Life Science Night Dec. 9, 2025
16.12.2025 klo 09.30 Aiforia Technologies
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.